C-CAR031

· Shanghai AbelZeta Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for C-CAR031, covering 2026-01-02 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer [Phase 1]

See pricing